Immutep (IMMP) Assets Average (2012 - 2025)
Immutep (IMMP) posted Assets Average of $98.6 million for Q4 2025, down 10.28% on a QoQ basis from $109.9 million in Q2 2025, and down 21.78% year-over-year from $126.0 million in Q4 2024.
Immutep (IMMP) Assets Average (2012 - 2025) Analysis & Trends
Immutep's Assets Average history runs 14 years deep, the most recent figure standing at $98.6 million for Q4 2025.
- Quarterly Assets Average fell 21.78% year-over-year to $98.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $98.6 million (down 21.78% YoY) and the FY2025 annual result came in at $116.7 million, up 0.86% from the prior year.
- Assets Average was $98.6 million for Q4 2025 at Immutep, down from $109.9 million in the prior quarter.
- Across five years, Assets Average topped out at $126.0 million in Q4 2024 and bottomed at $59.5 million in Q2 2021.
- A 5-year average of $88.8 million and a median of $85.0 million in 2022 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2021 — Assets Average jumped 98.81% — and 2025, when it declined 21.78%.
- Immutep's Assets Average stood at $75.4 million in 2021, then fell by 13.96% to $64.8 million in 2022, then soared by 38.12% to $89.6 million in 2023, then jumped by 40.72% to $126.0 million in 2024, then retreated by 21.78% to $98.6 million in 2025.
- Business Quant data shows IMMP's Assets Average at $98.6 million in Q4 2025, $109.9 million in Q2 2025, and $126.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.30 Bn |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | 98.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 98.59 Mn |
| Jun 30, 2025 | 109.89 Mn |
| Dec 31, 2024 | 126.04 Mn |
| Jun 30, 2024 | 106.72 Mn |
| Dec 31, 2023 | 89.57 Mn |
| Jun 30, 2023 | 77.53 Mn |
| Dec 31, 2022 | 64.85 Mn |
| Jun 30, 2022 | 80.38 Mn |
| Dec 31, 2021 | 75.37 Mn |
| Jun 30, 2021 | 59.53 Mn |
| Dec 31, 2020 | 43.22 Mn |
| Jun 30, 2020 | 29.94 Mn |
| Dec 31, 2019 | 26.63 Mn |
| Jun 30, 2019 | 29.26 Mn |
| Dec 31, 2018 | 35.09 Mn |
| Jun 30, 2018 | 30.92 Mn |
| Jun 30, 2017 | 26.52 Mn |
| Mar 31, 2017 | 27.70 Mn |
| Dec 31, 2016 | 30.20 Mn |
| Jun 30, 2015 | 12.06 Mn |